Table 2.
Evaluation of diabetic status including diabetic complications.
| Variable | n (%) |
|---|---|
| Duration of diabetes (years) | |
| <5 | 21 (6.98) |
| 5–10 | 30 (9.97) |
| >10 | 250 (83.05) |
| HbA1c (%) | |
| Mean (min, max) | 8.3 (5.4, 15.5) |
| <7 | 61 (20.27) |
| 7–8 | 102 (33.89) |
| >8 | 138 (45.84) |
| Renal function | |
| Albuminuria | |
| Present | 86 (28.57) |
| Absent | 215 (71.43) |
| eGFR (ml/min/1.73 m 2 ) | |
| Mean (min, max) | 78 (24, 110) |
| Normal (≥90) | 156 (51.83) |
| Mild (60–89) | 100 (33.22) |
| Moderate (30–59) | 44 (14.62) |
| Severe (<30) | 1 (0.33) |
| Retinopathy | |
| Present | 67 (22.26) |
| Absent | 234 (77.74) |
| Neuropathy | |
| Present | 58 (19.27) |
| Absent | 243 (80.73) |
| Peripheral vascular disease | |
| Present | 6 (2.01) |
| Absent | 293 (97.99) |
| Stroke | |
| Present | 16 (5.32) |
| Absent | 285 (94.68) |
Total number of patients evaluated were n = 301 except for peripheral vascular disease, n = 299; eGFR, estimated glomerular filtration rate.